EdgarScope

Free, fast access to the SEC EDGAR database. Search 10-K, 10-Q and 8-K filings for every registered U.S. public company.

Browse

Filing Search
All Tickers A–Z
About EdgarScope

Related Research

A filing tells you what happened. For what it means, our companion site breaks down U.S. earnings reports, dividend screens and beginner-friendly algorithmic trading strategies.

FNReportU.S. Equity Insights · written in Korean

© 2026 EdgarScope. Filing data is sourced from the U.S. Securities and Exchange Commission EDGAR system. EdgarScope is an independent service and is not affiliated with, endorsed by, or sponsored by the SEC. Nothing on this site constitutes investment advice.

KLRS SEC Filings | SEC Document SEARCH

Kalaris Therapeutics, Inc. (KLRS)

Ticker: KLRSCIK: 0001754068

35

Filings Found (Last 1 Year)

42026. 8. 27.

Vandekop Amy O'Leary (CIK 0002146984)

Insider trading report4

10-Q2026. 6. 30.

Kalaris Therapeutics, Inc. (KLRS) (CIK 0001754068)

Quarterly report10-Q

8-K2026. 8. 11.

Kalaris Therapeutics, Inc. (KLRS) (CIK 0001754068)

Current report8-K

42026. 8. 1.

KEATING LAURIE (CIK 0001620743)

Insider trading report4

42026. 7. 20.

Bayko Liisa Ann (CIK 0002145720)

Insider trading report4

8-K2026. 7. 14.

Kalaris Therapeutics, Inc. (KLRS) (CIK 0001754068)

Current report8-K

8-K2026. 7. 17.

Kalaris Therapeutics, Inc. (KLRS) (CIK 0001754068)

Current report8-K

8-K2026. 7. 3.

Kalaris Therapeutics, Inc. (KLRS) (CIK 0001754068)

Current report8-K

42026. 6. 3.

Jovan-Embiricos Morana (CIK 0001575745)

Insider trading report4

42026. 6. 3.

Ferrara Napoleone (CIK 0001744779)

Insider trading report4

42026. 6. 3.

Hallal David (CIK 0001457477)

Insider trading report4

42026. 6. 3.

AKKARAJU SRINIVAS (CIK 0001253170)

Insider trading report4

42026. 6. 3.

Dybbs Michael (CIK 0001601264)

Insider trading report4

42026. 6. 3.

ADAMIS ANTHONY P (CIK 0001277479)

Insider trading report4

42026. 6. 3.

PATTERSON LEONE D (CIK 0001233539)

Insider trading report4

8-K2026. 6. 3.

Kalaris Therapeutics, Inc. (KLRS) (CIK 0001754068)

Current report8-K

42026. 5. 20.

AKKARAJU SRINIVAS (CIK 0001253170)

Insider trading report

10-Q2026. 3. 31.

Kalaris Therapeutics, Inc. (KLRS) (CIK 0001754068)

Quarterly report10-Q

8-K2026. 5. 12.

Kalaris Therapeutics, Inc. (KLRS) (CIK 0001754068)

Current report8-K

8-K2026. 4. 8.

Kalaris Therapeutics, Inc. (KLRS) (CIK 0001754068)

Current report8-K

42026. 3. 19.

Hagen Brett R (CIK 0001681782)

Insider trading report4

42026. 3. 19.

Oxtoby Andrew (CIK 0001765473)

Insider trading report4

42026. 3. 19.

Gall Matthew (CIK 0001816194)

Insider trading report4

42026. 3. 19.

Feinsod Matthew (CIK 0001716950)

Insider trading report4

10-K2025. 12. 31.

Kalaris Therapeutics, Inc. (KLRS) (CIK 0001754068)

Annual report10-K

8-K2026. 3. 17.

Kalaris Therapeutics, Inc. (KLRS) (CIK 0001754068)

Current report8-K

8-K2026. 3. 9.

Kalaris Therapeutics, Inc. (KLRS) (CIK 0001754068)

Current report8-K

42025. 12. 18.

AKKARAJU SRINIVAS (CIK 0001253170)

Insider trading report

42025. 12. 22.

AKKARAJU SRINIVAS (CIK 0001253170)

Insider trading report

8-K2025. 12. 17.

Kalaris Therapeutics, Inc. (KLRS) (CIK 0001754068)

Current report8-K

8-K2025. 12. 17.

Kalaris Therapeutics, Inc. (KLRS) (CIK 0001754068)

Current report8-K

10-Q2025. 9. 30.

Kalaris Therapeutics, Inc. (KLRS) (CIK 0001754068)

Quarterly report10-Q

8-K2025. 11. 12.

Kalaris Therapeutics, Inc. (KLRS) (CIK 0001754068)

Current report8-K

42025. 11. 3.

Gall Matthew (CIK 0001816194)

Insider trading report4

8-K2025. 10. 28.

Kalaris Therapeutics, Inc. (KLRS) (CIK 0001754068)

Current report8-K

PreviousPage 1 of 2Next